[1] [1] United Nations Office on Drugs and Crime (UNODC). Current NPS Threats. Volume IV. 2021, 11.

[2] [2] European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). New Psychoactive Substances: Global Markets, Global Threats and the COVID-19 Pandemic-an Update From the EU Early Warning System, 2020, 12.

[3] [3] Brandt S D, King L A, Evans-Brown M. Drug Testing and Analysis, 2014, 6: 587.

[4] [4] European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Synthetic Cannabinoids in Europe. 2017, 6.

[5] [5] Potts A J, Cano C, Thomas S H L, et al. Clinical Toxicology, 2020, 58(2): 82.

[7] [7] Liu C M, Jia W, Hua Z D. Drug Testing and Analysis, 2017, 9: 1251.

[8] [8] Shevyrin V, Melkozerov V, Nevero A, et al. Forensic Science International, 2014, 242: 72.

[9] [9] Guirguis A, Girotto S, Berti B, et al. Forensic Science International, 2017, 273: 113.

[10] [10] Jones L E, Stewart A, Peters K L, et al. Analyst, 2016, 141: 902.

[11] [11] Qian Z H, Jia W, Li T, et al. Drug Testing and Analysis, 2017, 9, 51.

[14] [14] Liu C M, He H Y, Xu L, et al. Drug Testing and Analysis, 2020, 13(3): 720.